Working… Menu

Cannabidiol for Fibromyalgia (The CANNFIB Trial) (CANNFIB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04729179
Recruitment Status : Not yet recruiting
First Posted : January 28, 2021
Last Update Posted : January 28, 2021
Information provided by (Responsible Party):
Marius Henriksen, Frederiksberg University Hospital

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 1, 2022
Estimated Study Completion Date : February 10, 2023
Sundhedsstyrelsen, Callesen H, von Bülow C, Birkefoss K, Rasmussen M (2018) Nationale kliniske retningslinjer for udredning og behandling samt rehabilitering af patienter med genrelaliserede smerter i bevægeapparatet.
Lov om forsøgsordning med medicinsk cannabis. (2018).
Nabilone. (2018)
Banerjee S, McCormack S Medical Cannabis for the Treatment of Chronic Pain: A Review of Clinical Effectiveness and Guidelines. Ottawa: CADTH; 2019 Jul. (CADTH rapid response report: summary with critical appraisal).
Fisher, A. G. (2010) Assessment of Motor and Process Skills: Development, Standardization, and Administration Manual. Fort Collins, Colorado: Three Star Press.
Sens Motion (2020) Discrete Wearable Acticity Sensor for Healthcare and Research.
ImpediMed, SFB7 (2020) ImpediMed.
Pro.medicin Information til sundhedsfaglige (2018) Sativex.
Greenwich Biosciences I (2020) Epidiolex Highlights of Prescibing Information.
(2020) Epidyolex Summary of product characteristics.